Over 14 Million People Could Die from US Foreign Aid Cuts: Study
The study in the prestigious Lancet journal was published as world and business leaders gather for a UN conference in Spain this week hoping to bolster the reeling aid sector.
The US Agency for International Development (USAID) had provided over 40% of global humanitarian funding until Donald Trump returned to the White House in January.
Two weeks later, Trump's then-close advisor – and world's richest man – Elon Musk boasted of having put the agency "through the woodchipper".
The funding cuts "risk abruptly halting – and even reversing – two decades of progress in health among vulnerable populations," warned study co-author Davide Rasella, a researcher at the Barcelona Institute for Global Health (ISGlobal).
"For many low- and middle-income countries, the resulting shock would be comparable in scale to a global pandemic or a major armed conflict," he said in a statement.
Looking back over data from 133 nations, the international team of researchers estimated that USAID funding had prevented 91 million deaths in developing countries between 2001 and 2021.
They also used modelling to project how funding being slashed by 83% – the figure announced by the US government earlier this year – could affect death rates.
The cuts could lead to more than 14 million avoidable deaths by 2030, the projections found. That number included over 4.5 million children under the age of five – or around 700,000 child deaths a year.
For comparison, around 10 million soldiers are estimated to have been killed during World War I.
Programmes supported by USAID were linked to a 15% decrease in deaths from all causes, the researchers found. For children under five, the drop in deaths was twice as steep at 32%.
USAID funding was found to be particularly effective at staving off preventable deaths from disease.
There were 65% fewer deaths from HIV/AIDS in countries receiving a high level of support compared to those with little or no USAID funding, the study found. Deaths from malaria and neglected tropical diseases were similarly cut in half.
'Time to scale up'
After USAID was gutted, several other major donors including Germany, the UK and France followed suit in announcing plans to slash their foreign aid budgets.
These aid reductions, particularly in the European Union, could lead to "even more additional deaths in the coming years," study co-author Caterina Monti of ISGlobal said.
But the grim projections for deaths were based on the current amount of pledged aid, so could rapidly come down if the situation changes, the researchers emphasised.
Dozens of world leaders are meeting in the Spanish city of Seville this week for the biggest aid conference in a decade. The US, however, will not attend.
"Now is the time to scale up, not scale back," Rasella said.
Before its funding was slashed, USAID represented 0.3% of all US federal spending.
"US citizens contribute about 17 cents per day to USAID, around $64 per year," said study co-author James Macinko of the University of California, Los Angeles.
"I think most people would support continued USAID funding if they knew just how effective such a small contribution can be to saving millions of lives."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
Trump voters in for a shock as $800 billion Medicaid cuts hit home in MAGA stronghold
Teresa McNab, a Trump voter from Knox County, Kentucky, came home after dropping her daughter at school and found her husband Jackie having a seizure on the floor. Jackie, who had blood clots, died despite Teresa trying to save him before the ambulance arrived. He was only 45. Teresa and her daughter had to sell lemonade to raise money for his burial and gravestone. One small relief was that Medicaid paid Jackie's hospital bills. Teresa's story shows how important Medicaid is for poor families in rural areas like Knox County. But now that support is under threat due to Trump's plan to cut up to $800 billion from Medicaid, as stated by Telegraph report. Big Medicaid cuts may hurt Trump's own voters Trump wants the cuts to help fund $3.7 trillion in tax cuts, and is pushing lawmakers to pass it by July 4. These cuts would make 16 million people lose health insurance by 2034, according to the Congressional Budget Office (CBO). Even though Republicans say the bill will help household income, there's fear it will mostly hurt the poor people who actually voted for Trump. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 15 Most Beautiful Female Athletes in the World Click Here Out of the 200 countries that depend most on Medicaid, 84% voted for Trump in 2024. Knox County, where 72% voted for Trump, is one of the poorest places in the U.S. and 68% of people use public health insurance. These numbers show how risky this move could be for Trump politically, as mentioned in the report by Telegraph. Trump's former chief strategist Steve Bannon warned the bill might fail because 'MAGA is on Medicaid.' Pollster Frank Luntz says hardcore Trump fans will still support him even if they lose benefits. But Luntz also said working-class voters may turn against Trump if the cuts hurt them directly. Medicaid started in 1965 to help low-income people with healthcare. Live Events Medicare is for people over 65 and fully funded by the federal government. Medicaid is for low-income people and funded by both states and the federal government. Before Obama's Affordable Care Act (ACA) in 2010, adults without kids were mostly not eligible for Medicaid, as per the report by Telegraph. The ACA let more low-income adults qualify, dropping the number of uninsured Americans from 44 million to 25 million. Trump's bill could undo those gains by cutting $793 billion from Medicaid over 10 years. Kentucky could lose $21 billion in federal funding and 277,000 people may lose coverage, says research group KFF. ALSO READ: Musk escalates feud with Trump, throws support behind nemesis Thomas Massie for his re-election New work rules and paperwork may make people lose coverage A big change in the bill is a new requirement to work 80 hours a month to keep Medicaid under ACA rules, saving $344 billion. The bill also saves $64 billion by making people re-check their eligibility every 6 months instead of once a year. Darren Bullock, a Trump voter who left the Democrats, might lose his Medicaid because of the new work rules, as mentioned by the report by Telegraph. Darren says jobs are hard to get in rural areas like Knox County, especially since he has no car, phone, or public transport access. Jennifer Tolbert from KFF warns that people aged 55–64, who often retired early from tough jobs, are most at risk. She says even people who do work might lose Medicaid just because they can't keep up with the extra paperwork. Teresa McNab, who now works as a full-time cook, says she can meet the work hours but has no time to do the paperwork due to caring for her daughter and elderly mom. Medicaid is also key to drug rehab programs in Kentucky, especially with the region's opioid crisis. Chris Ross, a former drug addict, says Medicaid paid for his treatment and helped him turn his life around. He now has a job, is married, and got custody of his kids, all thanks to Medicaid support. Daniel Phipps, who runs a rehab group, says most of his patients are on Medicaid, and cuts could harm these services badly, as stated by Telegraph. While the Republican bill exempts people in rehab from work rules, they might still lose coverage if they can't meet reporting demands. Tolbert adds that local hospitals in poor areas will lose money and may cut back staff or services as more people go uninsured. Politically, this could hit Trump hard in countries like Knox, where people strongly vote Republican but rely heavily on Medicaid. Chris Ross said people can't just ignore such big threats to their survival — even if they're loyal Trump voters, according to the report by Telegraph. FAQs Q1. What is Trump's plan for Medicaid? Trump wants to cut up to $800 billion from Medicaid to help pay for tax cuts. This may cause millions of people to lose their health insurance. Q2. Who will be most affected by these Medicaid cuts? Low-income families, especially in rural places like Knox County, Kentucky, where many people voted for Trump, could lose coverage or face harder rules.
Mint
5 hours ago
- Mint
A promising depression drug works. Psychedelics are back.
Positive data on depression treatment based on a drug related to the psychedelic DMT is breathing life into shares of biotechs working on psychedelic medicines, after years of disappointments. Just as top Trump administration health officials have begun to show a more receptive attitude to psychedelics, atai Life Sciences and Beckley Psytech said Tuesday that patients with difficult-to-treat depression symptoms who took Beckley's drug BPL-003 saw improvement in an eight-week trial. Atai is in the process of acquiring Beckley. Patients on a higher dose of BPL-003 had an average decrease of 11.5 points on a rating scale that tracks depression symptoms. That compared with a 5.8 point drop among patients in the control group, who received a tiny dose of BPL-003. The companies will need to continue testing BPL-003. But analysts said Tuesday that based on the results, they see the drug eventually hitting $1 billion in annual sales. 'The dataset should instill confidence in a $1B+ drug," Jefferies analyst Andrew Tsai wrote in a research note. Atai shares were up 24% at midday. Shares of other biotechs working on psychedelic drugs took off as well: Compass Pathwards climbed 13%, while shares of MindMed were up 5.4%. The Beckley drug, BPL-003, is a nasal spray version of the psychedelic 5-MeO-DMT, a close relation to DMT and other similar psychedelics. A long list of biotechs have been looking toward psychedelic medicines in recent years. The aim is to find ways to treat neurological conditions like depression and post-traumatic stress disorder that have proven hard to cure with existing medicines. None have been approved by the Food and Drug Administration so far, though in 2019, Johnson & Johnson received FDA permission to sell a depression medicine called Spravato, which is a derivative of the dissociative anesthetic ketamine. The field hit a major roadblock last summer, when the FDA rejected an application from a private company called Lykos Therapeutics for approval of a treatment protocol for PTSD that combined use of the drug MDMA with talk therapy. At the time, analysts said that other psychedelic treatments might be easier to get approved than Lykos's MDMA treatment, for reasons having to do with the specifics of the Lykos protocol. Now, the positive data from atai and Beckley's drug comes as attitudes within the FDA appear to be shifting in favor of psychedelics. In an interview with the reality show fitness expert Jilian Michaels on NewsNation last month, FDA Commissioner Dr. Marty Makary suggested he was very open to approving psychedelic therapies. 'When I listen to the individuals who have tried some of these for real medical conditions – post-traumatic stress disorder, severe refractory depression – people tell me that they believe that psilocybin was successful, was curative, or significantly helped their severe mood disorder," Makary said. 'I'm saying we have to listen to doctors who have these experiences. And this is one of our top priorities at FDA: To listen to doctors, to listen to patients." Those comments, and similar rhetoric from Robert F. Kennedy Jr., the U.S. health secretary, point to a potentially friendly attitude among regulators toward BPL-003 and similar medicines. In the results announced Tuesday, atai and Beckley said that the two higher dose levels of BPL-003 they tested led to 'statistically significant improvements" in depression symptoms as soon as one day after treatment. The companies said that patients were ready to leave the treatment center two hours after receiving the medication on average. Atai noted that patients who take Johnson & Johnson's Spravato need to stay at their doctor's office for two hours after taking the medicine, which sets a precedent for a similar protocol.
Hindustan Times
6 hours ago
- Hindustan Times
Orthopedic surgeon says 'even modest weight loss' can reduce osteoarthritis risk: Here's everything women should know
According to the World Health Organisation (WHO), more than 60 percent of the 528 million people with osteoarthritis (OA) globally are women, and 73 percent of those affected are over the age of 55. The WHO reports that the knee is the most commonly affected joint, followed by the hip and hand. Also read | Nearly one billion people globally will have osteoarthritis by 2050: Lancet study Osteoarthritis (OA) is a common joint disorder that affects many women. (Freepik) In an interview with HT Lifestyle, Dr Sharmila Tulpule, orthopaedic surgeon, regenerative medicine specialist, and founder and director of Orthobiologix Biotech Pvt Ltd, said that osteoarthritis, long thought of as a 'wear-and-tear' disease, has become incredibly complex, especially for women. The prevalence of osteoarthritis, a type of joint disorder that occurs due to cartilage breakdown in the joints, is expected to increase with ageing populations and rising rates of obesity and injuries. By understanding the causes, symptoms, and treatment options for OA, you can take steps to manage the condition and improve your quality of life. According to Dr Tulpule, below are the factors concerning osteoarthritis in women: Hormonal changes and menopause ● Estrogen decline during menopause accelerates cartilage degradation, increasing OA risk. ● Hormone replacement therapy (HRT) may offer some benefits but requires careful consideration due to potential risks. Obesity and metabolic factors ● Obesity is a significant risk factor for OA, particularly in weight-bearing joints like the knees. ● Excess weight increases joint stress and systemic inflammation, exacerbating OA symptoms. ● Even modest weight loss can reduce OA risk and improve joint function. Physical activity and joint health ● Regular, moderate physical activity strengthens muscles around joints, enhancing mobility and reducing pain. ● Conversely, sedentary lifestyles contribute to joint stiffness and muscle weakness. Mental health and quality of life ● OA can lead to depression and anxiety, particularly in women, affecting overall well-being. ● Addressing mental health is crucial for effective OA management and improving quality of life. By understanding the risk factors, symptoms, and treatment options for OA, women can take steps to manage the condition and improve their quality of life. (Freepik) What to know about regenerative therapies Dr Tulpule said, 'Regenerative therapies offer a more holistic approach by addressing the underlying causes of OA rather than merely alleviating symptoms. They are particularly beneficial for women seeking alternatives to invasive surgeries and medications.' According to Dr Tulpule, stem cell therapy holds promise as a regenerative treatment for knee osteoarthritis, offering potential benefits in pain reduction and functional improvement. Explaining platelet-rich plasma (PRP) therapy, Dr Tulpule said it utilises growth factors from the patient's own blood to stimulate tissue repair and reduce inflammation. 'Studies indicate that PRP can provide longer-term pain relief and functional improvement compared to traditional treatments like hyaluronic acid (HA) injections,' she said. Dr Tulpule added that gold-induced cytokine therapy is a novel regenerative treatment that involves incubating the patient's own blood with gold particles, enhancing the anti-inflammatory and reparative properties of platelets. Studies have shown that it can lead to significant improvements in pain and function in patients with knee OA, with minimal adverse effects, she said. Management and prevention 'For women, osteoarthritis is not just a joint issue — it intertwines with hormonal health, body weight, lifestyle, mental wellness, and occupational context,' Dr Tulpule said. According to her, a nuanced approach means: 1. Advocating early detection especially during menopause. 2. Promoting preventive strategies combining diet, weight management, and exercise. 3. Considering hormone-based therapies for symptomatic relief when appropriate. 4. Supporting women's mental health alongside physical care. 5. Raising community awareness on how everyday activities shape OA risk. Dr Tulpule concluded, 'By addressing the unique facets of OA in women, clinicians can shift from reactive interventions to proactive, personalised care. This not only delays disease progression, but preserves mobility, dignity, and quality of life for millions of women worldwide.' Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
